Kiniksa Pharmaceuticals Chairman and CEO Sanj K Patel Reports $14.33 Million Sale of Common Shares

Bitget2026/11/06 21:53

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Kiniksa Pharmaceuticals International Chairman and CEO Sanj K. Patel sold 151,300 Class A Ordinary Shares on November 4, 2026.
Reported sale prices ranged from $92.35 to $96.05 per share.
Patel also exercised options for 145,763 Class A Ordinary Shares at $17.92 per share that day.
Following the transactions, he indirectly held 976,643 Class A Ordinary Shares through three trusts.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kiniksa Pharmaceuticals International plc published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001532218-26-000020), on November 06, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Kiniksa Pharmaceuticals Chairman and CEO Sanj K Patel Reports $14.33 Million Sale of Common Shares

You may also like

Crypto prices